For this reason, ipratropium was not recommended in asthma, except in acute severe asthma management ... effect on top of the current asthma treatment. The first large study on unselected moderate ...

A lot of patients with asthma, especially if it's in the more severe category, we have them use a device called a peak flow meter. It's a simple handheld device, and it can measure how much flow ...

has a place in the effort to avert acute attacks; however, its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward ...

If you have asthma or severe asthma, consider adding the following ... changes are meant to complement your existing asthma treatment. You shouldn’t stop using prescribed asthma medications ...

Nebulisation is a life-saving tool for individuals with respiratory problems offering a safe and effective way to deliver ...

Collaborative efforts in R&D are also vital for driving innovation in asthma treatments. DelveInsight's severe asthma pipeline report depicts a robust space with 40+ active players working to ...

If severe lung disease is also present ... He says that asthma treatment tends to fall into two major categories: rescue medications that dilate the airway during an asthma attack and maintenance ...

Scientists on Monday hailed a breakthrough for severe asthma treatment as a study found that the condition can be controlled by a regular injection of an antibody, eliminating the need for an inhaler.

Airsupra (PT027), a new asthma rescue treatment ... risk of severe exacerbations regardless of their disease severity or level of control. Current albuterol rescue inhalers alleviate acute ...

Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...

Stanley Fineman, MD, MBA First of all, asthma is a potentially life threatening situation when you have a severe acute attack ... need to reevaluate your treatment. Stanley Fineman, MD, MBA ...